ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Case Report

J Med Allied Sci. 2020; 10(2): 129-132


A case of ulcerative livedoid vasculopathy treated successfully with pentoxifylline and colchicine

Farheen Kahkashan Ahmed, Kallappa Chennappa Herakal, Karjigi Siddalingappa, Mohammed Abdul Samad.



Abstract
Download PDF Post

Livedoid vasculopathy (LV) is a dermatopathy characterized by skin ulceration consequential to chronic thombo-occulusive process. It is sometimes idiopathic or occurs consociated with chronic venous disease, thrombophelibitis, hyper coagulable state, protein C deficiency, factor VII deficiency, antiphospholipid antibody syndrome and hyperhomocystinemia. LV presents as grouped, painful, voilaceous macules, papules and patches with a proclivity to ulcerate over a long span of time. Dependent sites of the legs are affected, often bilaterally. Discrete ulcers are painful, small, angulated and coalesce at places to form bigger ulcers. On healing they leave behind atrophic, porcelain scars, surrounded by telangiectasia termed "atrophie blanche". We present a case of LV in a 22 year old female who presented with painful ulcers around the ankles for 8 months. Ulcers were covered with thick crust, and were painful on palpation. Skin biopsy revealed dermal vessel walls thickening and hyaline changes and their lumen had fibrin deposition, intra-luminal thrombosis, thus confirming the diagnosis of livedoid vasculopathy. Ulcers healed on treatment with pentoxifylline and colchicine.

Key words: Atrophie blanche, Livedoid vasculopathy, Small vessel venulitis, Ulcer







Bibliomed Article Statistics

33
42
36
24
22
20
26
20
24
29
33
2
R
E
A
D
S

20

45

12

16

15

8

7

13

14

29

26

1
D
O
W
N
L
O
A
D
S
050607080910111201020304
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.